Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTimirci\\-Kahraman, O.
dc.contributor.authorKaraaslan, Z.
dc.contributor.authorTuzun, E.
dc.contributor.authorKurtuncu, M.
dc.contributor.authorBaykal, A. T.
dc.contributor.authorGunduz, T.
dc.contributor.authorTuzuner, M. B.
dc.contributor.authorAkgun, E.
dc.contributor.authorGurel, B.
dc.contributor.authorEraksoy, M.
dc.contributor.authorKucukali, Cem Ismail
dc.date.accessioned2025-10-16T15:24:09Z
dc.date.issued2019
dc.identifier.doi10.1007/s13760-018-0954-4
dc.identifier.otherWOS:000461397400013
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8068
dc.publisherSPRINGER HEIDELBERG
dc.sourceACTA NEUROLOGICA BELGICA
dc.subjectMultiple sclerosis
dc.subjectClinically isolated syndrome
dc.subjectHomeobox protein Hox\\-B3
dc.subjectMass spectrometry
dc.subjectProteomics
dc.titleIdentification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS